Atlas Trials

Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer

Clinical trial NCT01676818 · COMPLETED

Trial details

NCT number
NCT01676818
Sponsor
University of Southern California
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Cervical CancerStage IIIA Cervical CancerStage IIIB Cervical CancerStage IVA Cervical CancerStage IVB Cervical Cancer
Start date
2012-08-09
Primary completion
2021-02-21
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.